New antibiotic combination treatment to save 2 Cystic fibrosis patient life

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-05-30 03:30 GMT | Update On 2022-05-30 09:36 GMT

Researchers at Aston University has developed a new combination of antibiotics that helps in saving the life of cystic fibrosis patient.

Dr Jonathan Cox, senior lecturer in microbiology in Aston University's College of Health and Life Sciences and his team discovered this combination of antibiotics.

Imipenem/Relebactam with amoxicillin was used as a combination and it was discovered that this combination is highly effective against potentially deadly Mycobacterium abscessus - a bacterium that can cause serious lung infections in people with various chronic lung diseases such as cystic fibrosis.

A cystic fibrosis patient, received the Aston University combination of antibiotics as part of a complex treatment regime, including an experimental therapy known as phage therapy, which uses viruses to treat bacterial infections.

The combination successfully treated the patient's infection and resulted in their being able to receive a life-saving lung transplant.

The research has been published in the journal Cell, and states: "The combination of phage and antibiotics did not result in greater antibiotic resistance." This means that the combined treatment was successful. And infection was eradicated and enabled the patient to receive the lifesaving lung transplant.

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr B.P. RAHUL

Dr B.P.RAHUL (MBBS) has completed his MBBS from Maulana Azad Medical College(MAMC), New Delhi. His areas of interest include Internal medicine, Orthopedics, surgery, and paediatrics. He has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. he can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

New antibiotic combination treatment to save 2 Cystic fibrosis patient life

Similar News

Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ?

WHO Leads Global Call to Include Pregnant, Lactating Women in TB Research

COVID-19 Linked to Higher Risk of Asthma and Sinusitis: Study Finds

PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control

Study Reveals Social Factors that May Triple the Risk of Long Covid

Maternal RSV Vaccine Cuts Infant Hospitalizations by 72 Percent: Study Finds

Micro labs to offer mucolytic solution for respiratory care with its recently launched Pulmucus range

Why Asthma Often Comes Back After Stopping Biologic Drugs? Study Sheds Light